Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Citeline
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Citeline
-
Did you know that the reach of
#pharmaintelligence is unparalleled with over 350 experts supplying comprehensive news &#analysis. Find out how to boost your sales with#pharmaintelligence here http://bit.ly/2GxjOGP pic.twitter.com/6UMi2CLKkm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Discover new opportunities for
#marketing success with partnering with the industry experts that#pharma leaders trust and rely on. Click to download your media kit here http://bit.ly/2vC3diZ pic.twitter.com/qV31QzUsGq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Wondering how you will fill your pipeline & hit your sales numbers in 2020? By partnering with
#PharmaIntelligence, you can generate high quality leads, fill your pipeline & create bespoke#thoughtleadership. Find out more here http://bit.ly/2GN6qyx pic.twitter.com/uBvyJ7fZdR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Did you get your entry in for the 2020
#CitelineAwards? Have you seen our illustrious judging panel who will choosing the finalists & winners! Take a look here to read more http://bit.ly/2NZ5Y3R pic.twitter.com/Hemv10teqv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our
#sponsorship packages offer unique marketing opportunities, ranging from category sponsorship to the prestigious headline sponsor. Find out how you can cement your position in the clinical R&D sector http://bit.ly/36yRNJf#CitelineAwardspic.twitter.com/QU0sXL0I9T
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What are the Global Market Access Trends that made 2019? Hear from our
#DMHC experts as they use data to examine the challenges and opportunities in#marketaccess. Register here to listen to this & more of our top 2019#webinars http://bit.ly/35xnbHK pic.twitter.com/rNkfK2ABAr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
[WHITEPAPER] The 5 Year Clinical Landscape and Trends in Breast Cancer. Download your copy here http://bit.ly/2FwtHnA
#BreastCancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A few more hours until our
#webinar with#Abzena. Will you be joining us? There are still spaces available. Register here http://bit.ly/2RplEyl pic.twitter.com/8AaHN6yrPm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join the Senior Director - Bioassays at
#Abzena as they discuss how to rank clones with high sequence#homology based on#immunogencity risk. Register here http://bit.ly/38cUpOr pic.twitter.com/H2jsXR8d6b
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What were the top trends in 2018 that influenced 2019 R&D? Discover more in our
#webinar recording of the Pharma R&D Review here: http://bit.ly/2tM9VBG pic.twitter.com/TfuLuZF4Oq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Get an insight into the recently approved and late-stage
#drugs for#breastcancer from#ESMO and#SABCS with our detailed whitepaper. Download your copy here http://bit.ly/37LRko7Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ENTRY DEADLINE EXTENSION! Missed Friday's entry deadline for the 2020
#CitelineAwards? We have extended the entry deadline for the 2020#CitelineAwards until Friday January 24th 2020! Don't miss out and get your entries in now! http://bit.ly/2G6KGNt pic.twitter.com/fbryb8RDG2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
[WEBINAR] Bringing In Silico Immunogenicity Prediction into the 21st Century with Augmented Intelligence. Join us January 23rd at 11am EDT. Register here http://bit.ly/371fDPa pic.twitter.com/IwCeewEHBA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Gain insights into the competitive landscape revealing priorities & strategies of industry sponsors and collaborators within the
#breastcancer clinical landscape in our#whitepaper here http://bit.ly/2QZUfCOHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join us on January 23rd at 11am EDT to discover how
#AugmentedIntelligence can bring in silico#immunogencity into the 21st century. Register here http://bit.ly/3757UPR pic.twitter.com/2mrbDx4ALb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
TODAY IS THE DAY!
It is the last day to get your entries in for the 2020 #CitelineAwards! Click here to enter the prestigious awards (formerly the#CARE_Awards)http://bit.ly/2QDr9JBHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Listen to the top
#clinical#webinars of 2019 here: http://bit.ly/2N9mlKWHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
TIme is running out! You have 1 day left to enter the
#CitelineAwards! Celebrate those who are innovating in the clinical R&D space! Click to get your entry in today http://bit.ly/30sTN4l pic.twitter.com/ES00l6qdR0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ArtificialIntelligence is slowly advancing into all avenues of#pharma, but have you adopted it? Did you use it in a#clinicaltrial this year? Let us know and enter the 2020#CitelineAwards! http://bit.ly/30njZxn pic.twitter.com/0ZpiFBxfbU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Do you have what it takes to be the BEST
#clinical research team of the year? Have you managed to get a new therapy through one or more#clinical phases? Did you answer YES to any of these? Then enter the 2020#CitelineAwards NOW! Entries close on Friday http://bit.ly/2FUMGIs pic.twitter.com/kRbDgmyDp9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.